2 transcripts
ICAD
Earnings call transcript
NASDAQ
2024 Q2
13 Aug 24
of women initially classified as low risk showed a substantial increase in risk at their subsequent mammogram.
Outside of the U.S., we participated
ICAD
Earnings call transcript
NASDAQ
2023 Q4
12 Mar 24
-- so the first step with the FDA once the FDA had released its final guidance was to resubmit the risk product and ask the FDA to classify it. They did
- Prev
- 1
- Next